Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 701–800 of 999
3-year mortality after acute myocardial infarction in patients with different diabetic status
Fojt, A., Kowalik, R., Gierlotka, M. J., Gąsior, M., Smeding, C., & Opolski, G. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16095 · Cited by 19
Kaul, U., Arambam, P., Sinha, S. K., Abhaichand, R. K., Parida, A. K., Banker, D. N., Mody, R., Khan, A., Sharma, R., Moorthy, N., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.10.082 · Cited by 12
Survival of multiple arterial grafting in diabetic populations: a 20-year national experience
Ren, J., Royse, C. F., Tian, D. H., Gupta, A. K., & Royse, A. G. (2023) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezad091 · Cited by 11
Gulsin, G. S., Τζίμας, Γ., Holmes, K.-R., Takagi, H., Sellers, S., Blanke, P., Koweek, L., Nørgaard, B. L., Jensen, J., Rabbat, M., et al. (2023) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.220276 · Cited by 11
Nauffal, V. D., Schwann, T. A., Yammine, M. B., Sleiman, K., Zein, M. H. E., Kabour, A., Engoren, M., & Habib, R. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.01.051 · Cited by 11
“In contradistinction to this study, almost all previous studies looking at long-term follow-up after CABG, with prior PCI, focused on the general population undergoing CABG, without a specific analysis of particular aspects of patient subgroups known to be associated with suboptimal outcomes after intracoronary stent…”
ResultFanari, Z., Weiss, S. A., Zhang, W., Sonnad, S. S., & Weintraub, W. S. (2014) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivu291 · Cited by 12
Casselman, F. P. A., van der Merwe, J., Ferrara, A., & Barbato, E. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.12.021 · Cited by 11
Ruszkowski, A., Schneider, C., Mohareri, O., & Salcudean, S. E. (2016) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra.2016.7487601 · Cited by 11
“CABG is the most common revascularization procedure and recent studies recommend CABG as a preferred revascularization strategy, indicating a rising number of future cases [3]-[4].”
MethodKim, C., Hong, S., Ahn, C., Kim, J., Kim, B., Ko, Y., Choi, D., Jang, Y., & Hong, M. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.08.064 · Cited by 11
Chandiramani, R., Chen, H., Aoi, S., Giustino, G., Claessen, B. E. P. M., Sartori, S., Aquino, M. B., Sorrentino, S., Cao, D., Goel, R., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28369 · Cited by 11
“Palmerini et al reported a metaanalysis of 19 trials including 10,944 patients, which showed a stroke rate at median follow-up of 12 months of approximately 1%, a finding that was corroborated in the Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREE…”
ResultMinimally invasive multivessel coronary bypass surgery: Angiographic patency data
Снегирев, М. А., Paivin, A. A., Denisyuk, D. O., Drozdova, O. A., Митусова, Г. М., Sichinava, L. B., Khvan, N. E., & Sharafutdinov, V. E. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14439 · Cited by 11
“Coronary artery bypass grafting (CABG) is the best treatment option for patients with multivessel coronary artery disease, particularly for those with diabetes mellitus.(1) Nevertheless, despite its proven long‐term benefits, CABG is characterized by significant invasiveness.”
BackgroundFerrari, G., Geijer, H., Cao, Y., Souza, D. S. R., & Samano, N. (2021) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2021.1900598 · Cited by 11
Neurological Complications in High-Risk Patients Undergoing Coronary Artery Bypass Surgery
Naito, S., Demal, T. J., Sill, B., Reichenspurner, H. C., Onorati, F., Gatti, G., Mariscalco, G., Faggian, G. G., Santini, F., Santarpino, G., et al. (2021) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.05.018 · Cited by 11
Hara, H., Watanabe, H., Esaki, J., Hori, Y., Hirao, S., Kanemitsu, N., Morimoto, T., Komiya, T., Minatoya, K., Kimura, T., et al. (2021) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-021-01711-4 · Cited by 11
External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI
Takahashi, K., Serruys, P. W. J. C., Fuster, V., Farkouh, M. E., Spertus, J. A., Cohen, D. J., Park, S., Park, D., Ahn, J., Onuma, Y., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.049 · Cited by 13
Self-citationRuszkowski, A., Mohareri, O., Lichtenstein, S. V., Cook, R., & Salcudean, S. E. (2015) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra.2015.7139812 · Cited by 11
“Recent studies recommend CABG as a preferred revascularization strategy, indicating a rising number of future cases [5],[6].”
BackgroundIncidence, Secular Trends, and Outcomes of Cardiac Surgery in Aboriginal Peoples
Sood, M. M., Tangri, N., Komenda, P. V. J., Rigatto, C., Khojah, S., Hiebert, B. M., Menkis, A. H., Tam, J. W., & Arora, R. C. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.06.003 · Cited by 10
Roh, J., Kim, Y., Ahn, J., Yun, S.-H., Lee, J. B., Ge, J., Wang, L., Park, G., Lee, J., Park, D., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.02.013 · Cited by 11
“Nevertheless, as the previous randomization studies had shown, the gap in readmission rate between the 2 groups was more prominent in the high SYNTAX tercile having multivessel disease compared with the low SYNTAX tercile because of the higher revascularization rate of the former.(27,28) The trend of readmission rate…”
ResultMolecular pathways activation in coronary artery bypass surgery
Parolari, A., Poggio, P., Myasoedova, V. A., Songia, P., Casado, A. P., Alamanni, F., & Tremoli, E. (2015) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000293 · Cited by 11
Ritsinger, V., Hero, C., Svensson, A., Saleh, N., Lagerqvist, B., Eeg‐Olofsson, K., & Norhammar, A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487316687860 · Cited by 11
“There is a lack of research regarding the benefits of coronary revascularisation in type 1 diabetes patients but there are at present no reasons to believe that the results would differ much from results in type 2 diabetes where revascularisation has led to improved survival rates.(26,27) Apart from microvascular comp…”
ResultGibbons, R. J., & Miller, T. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.018 · Cited by 11
CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine?∗
Boden, W. E., & Mancini, G. B. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.004 · Cited by 11
“Among this latter group, similar findings have been observed in both the BARI-2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) (5) and FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trials (7), and in meta-analyses that diab…”
ResultAdvancing the State of the Art in Surgical Coronary Revascularization
Puskas, J. D., Yanagawa, B., & Taggart, D. P. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.10.046 · Cited by 11
Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy
DOMANSKI, M. J., & Farkouh, M. E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.781 · Cited by 11
“The FREEDOM (Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes) (3) trial compared CABG to PCI with drug-eluting stents in patients with both diabetes (T1DM and T2DM) and multivessel CAD and showed that CABG is the revascularization procedure of choice in these patients.”
BackgroundSelf-citationManagement of acute coronary syndromes
Tardif, J.-C., L'Allier, P. L., & Fitchett, D. H. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.029 · Cited by 10
“In patients with diabetes and NSTE ACS and multivessel disease, CABGwith the use of internal mammary arterymay provide benefit over PCI when revascularization is indicated (70).”
Ren, J., Royse, C. F., & Royse, A. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072516 · Cited by 10
Hommels, T. M., Hermanides, R. S., Fabris, E., & Kedhi, E. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01844-1 · Cited by 13
Management of Acute Coronary Syndromes
Tardif, J., L'Allier, P. L., & FITCHETT, D. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.034 · Cited by 10
Gaudino, M. F. L., Franco, A. D., Dimagli, A., Biondi‐Zoccai, G., Rahouma, M., Perezgrovas‐Olaria, R., Soletti, G. J., Cancelli, G., Chadow, D., Spertus, J. A., et al. (2023) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2023.100591 · Cited by 13
Sechtem, U. P., Achenbach, S. S., Gitt, A. K., Marx, N., Kelm, M., & Schächinger, V. (2015) · Der Kardiologe · doi:10.1007/s12181-015-0652-x · Cited by 10
Vascular repair strategies in type 2 diabetes: novel insights.
Kuschnerus, K., Landmesser, U., & Kränkel, N. (2015) · PubMed Central · doi:10.3978/j.issn.2223-3652.2015.05.11 · Cited by 10
“These observations confirm the findings of the BARI 2D and FREEDOM trial which both favor CABG over PCI as revascularization strategy in patients with T2D and coronary artery disease (6,7).”
ResultLindblom, R. P. F., Lytsy, B., Sandström, C., Ligata, N., Larsson, B., Ransjö, U., & Swenne, C. L. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0148-4 · Cited by 10
“Complete revascularization in patients with severe coronary artery disease is optimally achieved with coronary artery bypass-grafting (CABG) [1–3].”
BackgroundFarooq, V., & Serruys, P. W. J. C. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.10.002 · Cited by 10
“(6-8,83) In SYNTAX, diabetes was shown not to be important for decision-making between CABG and PCI, since it lacked an interaction effect, i.”
BackgroundFanari, Z., Weiss, S. A., Zhang, W., Sonnad, S. S., & Weintraub, W. S. (2014) · PubMed · Cited by 14
Ganyukov, V. I., Tarasov, R. S., Shilov, A. A., Kochergin, N. А., & Barbarash, L. S. (2016) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2016-2-46-50 · Cited by 10
Ariyaratne, T. V., Ademi, Z., Huq, M. M., Rosenfeldt, F., Duffy, S. J., Parkinson, B., Yap, C., Smith, J. A., Billah, B., Yan, B. P., et al. (2018) · Applied Health Economics and Health Policy · doi:10.1007/s40258-018-0407-5 · Cited by 10
Diabetics have Inferior Long-Term Survival and Quality of Life after CABG
Hokkanen, M., Huhtala, H., & Järvinen, O. (2019) · International Journal of Angiology · doi:10.1055/s-0038-1676791 · Cited by 13
Panoulas, V. F., Ilsley, C. D. J., Kalogeras, K. I., Khan, H. R., Vela, M. M., Dalby, M. C. D., Kabir, T., Smith, R. D., Mason, M. J., Grocott-Mason, R. M., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz142 · Cited by 10
Li, H. R., Hsu, C. P., Sung, S., Shih, C. C., Lin, S. J., Chan, W., Wu, C., & Lu, T. (2017) · PubMed · doi:10.6515/acs20160623a · Cited by 11
Cui, K., Lyu, S., Song, X., Liu, H., Yuan, F., Xu, F., Zhang, M., Wang, W., Zhang, M., Zhang, D., et al. (2019) · Angiology · doi:10.1177/0003319719839885 · Cited by 10
Pölzl, L., Nägele, F., Graber, M., Hirsch, J., Lobenwein, D., Mitrovic, M., Mayr, A., Theurl, M., Schreinlechner, M., Pamminger, M., et al. (2020) · Trials · doi:10.1186/s13063-020-04369-0 · Cited by 10
Zhao, X., Xu, L., Jiang, L., Tian, J., Zhang, Y., Wang, D., Sun, K., Xu, B., Zhao, W., Hui, R., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01193-3 · Cited by 11
“These results are consistent with those of previous studies [3, 4, 33].”
MethodResultLi, S., Zhang, H., Xiao, C., Wang, R., & Wu, Y. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.15433 · Cited by 10
How does the Nature of an Excipient and an Atheroma Influence Drug-Coated Balloon Therapy?
Anbalakan, K., Toh, H. W., Ang, H. Y., Buist, M. L., & Leo, H. L. (2022) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-022-00626-2 · Cited by 10
Nusca, A., Piccirillo, F., Bernardini, F., Filippis, A. D., Coletti, F., Mangiacapra, F., Ricottini, E., Melfi, R., Gallo, P., Cammalleri, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137261 · Cited by 14
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort
Gohbara, M., Hibi, K., Morimoto, T., Kirigaya, H., Yamamoto, K., Ono, K., Shiomi, H., Ohya, M., Yamaji, K., Watanabe, H., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.08.043 · Cited by 10
New Approaches to Cardiovascular Surgery
Neely, R. C., Leacche, M., Byrne, C. R., Norman, A. V., & Byrne, J. G. (2014) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2014.07.006 · Cited by 12
“These patients have higher restenosis rates with DES, and worse long-term outcomes compared with CABG as demonstrated in the Synergy Between PCI With Taxus and Cardiac Surgery and Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease trials.(49,57,58) Patient…”
Ahn, J., Yoon, S., Roh, J., Lee, P. H., Chang, M., Park, H. W., Lee, J., Kang, S., Park, D., Lee, S., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.07.028 · Cited by 10
Kawecki, D., Morawiec, B., Dola, J., Wańha, W., Smolka, G. A., Pluta, A., Marcinkiewicz, K., Ochala, A. J., Nowalany-Kozielska, E., & Wojakowski, W. (2015) · Medical Science Monitor · doi:10.12659/msm.895095 · Cited by 10
Hybrid approach for coronary artery revascularization
Toeg, H. D., Al‐Atassi, T., Labinaz, M. X., May, M. R. L., & Ruel, M. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000112 · Cited by 10
“4% in FREEDOM) [55] or used one or more arterial conduits (97.”
BackgroundMethodInfluentialLiu, H., Xu, Z., Gu, H., Li, W., Chen, W., Sun, C., Zhao, K., Teng, X., Zhang, H., Jiang, L., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004496 · Cited by 11
Diabetes and multivessel disease: coronary artery bypass grafting remains king
Godoy, L. C., Rao, V. A., & Farkouh, M. E. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000550 · Cited by 13
Self-citationSalem, M. M., Maragkos, G. Α., Enríquez-Marulanda, A., Ascanio, L. C., Ravindran, K., Alturki, A. Y., Ogilvy, C. S., Thomas, A. J., & Moore, J. M. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.08.119 · Cited by 10
Zhang, Y., Yang, L., Zhang, W., & Liu, J. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14304-9 · Cited by 10
Polylysine Enriched Matrices: A Promising Approach for Vascular Grafts
Fusaro, L., Catoira, M. C., Ramella, M., Botto, F. S., Talmon, M., Fresu, L. G., Hidalgo‐Bastida, A., & Boccafoschi, F. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00281 · Cited by 10
Watanabe, H., Shiomi, H., Morimoto, T., Furukawa, Y., Nakagawa, Y., Andò, K., Kadota, K., Tazaki, J., Watanabe, H., Natsuaki, M., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28420 · Cited by 10
“Randomized controlled trials (RCTs) in the drug-eluting stent (DES) era have clearly demonstrated the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) in patients with complex multi-vessel coronary artery disease (CAD).(1,2) However, external validity of the findings…”
BackgroundMethodInfluentialCoronary Artery Revascularization in Chronic Kidney Disease: Time for a Randomized Trial
Baber, U., & Mehran, R. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.002140 · Cited by 13
“Cherry-Picking” Patients for Randomized, Controlled Trials—Reliving the Past…
Farooq, V., & Serruys, P. W. J. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.018 · Cited by 10
Actualización en cardiología intervencionista 2013
Hernández, F., Cuevas, J. R. R., del Blanco, B. G., & Trillo, R. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.028 · Cited by 9
Hirsch, D. S., Lau, B., Kushwaha, V. V., & Yong, K. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2406181 · Cited by 15
“The Future Revascularisation Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multives-sel Disease (FREEDOM) trial demonstrated a significant benefit of CABG over PCI in diabetic population, with a 27% relative risk reduction in MACE at a median follow-up of 3.8 years [294].”
MethodInfluentialDawson, L. P., Kobayashi, Y., Zimmermann, F. M., Takahashi, T., Wong, C. C. Y., Thériault-Lauzier, P., Pijls, N. H. J., Bruyne, B. D., Yeung, A. C., Woo, Y.-P. J., et al. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.06.003 · Cited by 9
Ferrari, G., Loayza, R., Azari, A., Geijer, H., Cao, Y., Carlsson, R., Bojö, L., Samano, N., & Souza, D. S. R. (2024) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-03057-3 · Cited by 11
Lee, S., Cho, Y. H., Sung, K., Kim, W. S., Lee, S., Kwon, W., Lee, J., Lee, S. H., Shin, D., Lee, S. Y., et al. (2025) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2025.06.034 · Cited by 9
Rezende, P. C., Hueb, W. A., Bocchi, E. A., Farkouh, M. E., Junior, C. V. S., Lima, E. G., Silva, E. E. R., Dallan, L. A. O., Gaiotto, F. A., Garzillo, C. L., et al. (2020) · Trials · doi:10.1186/s13063-020-04270-w · Cited by 9
Self-citationImplications of the ISCHEMIA trial on the practice of surgical myocardial revascularization
Ruel, M., Sun, L. Y., Farkouh, M. E., & Gaudino, M. F. L. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.07.123 · Cited by 9
Self-citationTherapeutic Options for Left Main, Left Main Equivalent, and Three-Vessel Disease
Glazier, J. J., Parra, B. M. R., & Kaki, A. (2021) · International Journal of Angiology · doi:10.1055/s-0041-1723977 · Cited by 9
Hamilton, G. W., Yeoh, J., Dinh, D. T., Reid, C. M., Yudi, M., Freeman, M., Brennan, A., Stub, D. A., Oqueli, E., Sebastian, M., et al. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.08.019 · Cited by 9
Causal fairness assessment of treatment allocation with electronic health records
Zhang, L., Richter, L. R., Wang, Z., Ostropolets, A., Elhadad, N., Blei, D. M., & Hripcsak, G. M. (2024) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2024.104656 · Cited by 13
“However, CABG is much more expensive than PCI and requires longer hospital stay, which could pose a financial challenge to some patients.”
BackgroundZhang, X., Li, Q., Rogatko, A., Tighiouart, M., Hardison, R. M., Brooks, M. M., Kelsey, S. F., Kaul, S., & Merz, C. N. B. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.543 · Cited by 11
The cost–effectiveness of strategies in coronary artery disease
Scudeler, T. L., Rezende, P. C., & Hueb, W. A. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.957681 · Cited by 9
Self-citationComments on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization
Cequier, A. R. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.12.004 · Cited by 9
Wu, Y., Su, T., Zhang, J., Shen, W., Ning, G., & Kong, Y. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12176 · Cited by 10
Benefit of revascularization for stable ischaemic heart disease: the jury is still out
Fassa, A.-A., Wijns, W. C., Kolh, P. H., & Steg, P. G. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht004 · Cited by 9
SYNTAX score may predict the severity of atherosclerosis of the ascending aorta
Yammine, M. B., Itagaki, S., Pawale, A. A., Toyoda, N., & Reddy, R. C. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.09.17 · Cited by 9
Kodumuri, V., Balasubramanian, S. S., Vij, A., Siddamsetti, S., Sethi, A., Khalafallah, R., & Khosla, S. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.12.039 · Cited by 9
Predialysis coronary revascularization and postdialysis mortality
Gaipov, A., Molnar, M. Z., Potukuchi, P. K., Sumida, K., Canada, R. B., Akbilgiç, O., Kabulbayev, K., Szabó, Z., Koshy, S. K. G., Kalantar‐Zadeh, K., et al. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.08.107 · Cited by 9
“947 Depression, n (%) 230 (24) 100 (26) 130 (22) .”
Costs Five Years After Off-Pump or On-Pump Coronary Artery Bypass Surgery
Wagner, T. H., Hattler, B. G. J., Bakaeen, F. G., Collins, J. F., Almassi, G. H., Quin, J. A., Grover, F. L., Bishawi, M. M., & Shroyer, A. L. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.07.075 · Cited by 9
The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes
CHILTON, R. J., Gallegos, K. M., Silva‐Cardoso, J., OLIVEROS, R. A., & Pham, S. V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1114-1 · Cited by 10
Non-ST Elevation Myocardial Infarction: Diagnosis and Management
Alahmad, Y., & Ali, M. T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.76241 · Cited by 12
de Andrade, P. J. N., Falcão, J. L. D. A. A., Falcão, B. D. A. A., & Rocha, H. A. L. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190027 · Cited by 9
Kezerle, L., Yohanan, E., Cohen, A., Merkin, M., Ishay, Y., Weinstein, J. M., & Cafri, C. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14892 · Cited by 9
Li, D., Gu, S., Liu, Y., Zhang, X., An, X., Yan, J., Wang, H., Guo, Y., & Su, P. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-2358 · Cited by 9
“In some large randomized clinical trials, the rate of occurrence of unavailable LIMA from all causes was 4–9% (20-22), which is similar to the 8.”
ResultImpact of Delay in Surgery on Outcome in Patients Undergoing Cardiac Revascularisation Surgery
Al-Omary, M. S., Williams, T. D., Brienesse, S. C., Khan, A. A., Graffen, S. C., Sheehan, A., Doolan, M., Walker, R., Boyle, A., Mejia, R., et al. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.09.935 · Cited by 9
Working towards an ERAS Protocol for Pancreatic Transplantation: A Narrative Review
Elango, M., & Papalois, V. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071418 · Cited by 11
Yamamoto, K., Matsumura‐Nakano, Y., Shiomi, H., Natsuaki, M., Morimoto, T., Kadota, K., Tada, T., Takeji, Y., Yoshikawa, Y., Imada, K., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021257 · Cited by 9
“1) Total number of stents 2 (2-4) 3 (2-4) 0.”
BackgroundInfluentialNishiyama, H., Funamizu, T., Iwata, H., Endo, H., Chikata, Y., Doi, S., Wada, H., Naito, R., Ogita, M., Kato, Y., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34164 · Cited by 11
Tasoudis, P., Varvoglis, D. N., Tzoumas, A., Doulamis, I. P., Tzani, A. I., Sá, M. P., Kampaktsis, P. Ν., & Gallo, M. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16805 · Cited by 9
“Indeed, in the ESRD population, some individual studies and prior meta‐analyses have shown improved survival after CABG.12,33,35,36 However, many discrepancies are noted between studies reporting solely on dialysis‐ dependent patients regarding survival.6,12–31,37,38 A possible interpretation of these discrepancies co…”
MethodResultInfluentialMinimally invasive off‐pump anaortic coronary artery bypass (MACAB)
Mavioğlu, İ., & Vallely, M. P. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.17180 · Cited by 9
“8% in the FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) study.(21) Again, at the ISMICS consensus conference, perioperative stroke rates for off‐pump and on‐pump CABG via sternotomy were 1.”
BackgroundKappetein, A. P., Mieghem, N. M. V., & Head, S. J. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.011 · Cited by 11
Revascularization in Patients with Diabetes: PCI or CABG or None at All
Mavromatis, K., Samady, H., & King, S. B. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0565-0 · Cited by 9
Self-citationHybrid strategy for unstable patients with severe carotid and cardiac disease requiring surgery
Méndiz, O., Fava, C. M., Lev, G. A., Valdivieso, L., Caponi, G., Alava, G. H., & Favaloro, R. R. (2014) · Cardiology Journal · doi:10.5603/cj.a2014.0001 · Cited by 9
“Although the long-term results of FREEDOM [21] and SYNTAX trials [22] clearly show that multivessel disease, mainly for those with diabetes mellitus and high Syntax Score, is still better treated with CABG; in our series, 20 of our patients required combined CABG plus AVR representing a higher surgical risk impossible…”
BackgroundCoronary artery bypass grafting in young patients - insights into a distinct entity
Fleißner, F., Warnecke, G., Cebotari, S., Rustum, S., Haverich, A., & Ismail, I. (2015) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-015-0266-1 · Cited by 9
“Although the recent long-term results from the SYNTAX [1], ASCERT [9], and FREEDOM [10] trials showed significantly better survival rates after CABG than after PCI, CABG rates are declining over the past years, while PCI rates increase accordingly [11].”
ResultSugumar, H., Lancefield, T. F., Andrianopoulos, N., Duffy, S. J., Ajani, A. E., Freeman, M., Buxton, B. B., Brennan, A., Yan, B. P., Dinh, D., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.01.096 · Cited by 9
“It is generally accepted that patientswith diabetesmellitus andMVD have superior long-term outcomes with CABG [8,11], but the effect of other comorbidities on outcomes and revascularization strategy is unclear.”
BackgroundInvasive coronary imaging: any role in primary and secondary prevention?
Mario, C. D., & Moreno, P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv323 · Cited by 9
“pass implantation more effective in the protection of patients with diffuse complex atherosclerosis, especially if diabetic.(2) Focusing treatment to flow limiting lesions may not prevent events caused”
BackgroundCastelvecchio, S., Menicanti, L., Garatti, A., Tramarin, R., Volpe, M., & Parolari, A. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.02.081 · Cited by 9
Stolker, J. M., Cohen, D. J., Kennedy, K. F., Pencina, M. J., Arnold, S. V., Kleiman, N. S., & Spertus, J. A. (2016) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2016.12.014 · Cited by 10
Self-citationInterventional Therapies for Heart Failure in Older Adults
Kolte, D. S., Abbott, J. D., & Aronow, H. D. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.009 · Cited by 10
Tsuneyoshi, H., Komiya, T., Kadota, K., Shimamoto, T., Sakai, J., Hiraoka, T., Wada, K., Kaneko, H., Fujimoto, Y., Furuichi, Y., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx031 · Cited by 9
“Several randomized prospective studies [10, 11] comparing CABG with PCI as a coronary revascularization strategy have been published over recent decades.”
Type 1 diabetes mellitus and coronary revascularization
Mamet, H., Petrie, M. C., & Rocchiccioli, P. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000166 · Cited by 9
Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus
Godoy, L. C., Tavares, C. A. M., & Farkouh, M. E. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.08.002 · Cited by 9
Self-citation
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.